199 related articles for article (PubMed ID: 32064471)
21. T2-Weighted Magnetic Resonance Imaging of Hepatic Tumor Guided by SPIO-Loaded Nanostructured Lipid Carriers and Ferritin Reporter Genes.
Lu CY; Ji JS; Zhu XL; Tang PF; Zhang Q; Zhang NN; Wang ZH; Wang XJ; Chen WQ; Hu JB; Du YZ; Yu RS
ACS Appl Mater Interfaces; 2017 Oct; 9(41):35548-35561. PubMed ID: 28944659
[TBL] [Abstract][Full Text] [Related]
22. nCP:Fe Nanocontrast Agent for Magnetic Resonance Imaging-Based Early Detection of Liver Cirrhosis and Hepatocellular Carcinoma.
Sridharan B; Devarajan N; Jobanputra R; Gowd GS; Anna IM; Ashokan A; Nair S; Koyakutty M
ACS Appl Bio Mater; 2021 Apr; 4(4):3398-3409. PubMed ID: 35014424
[TBL] [Abstract][Full Text] [Related]
23. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
Chen CY; Chen J; Xia CC; Huang ZX; Song B
J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
[TBL] [Abstract][Full Text] [Related]
24. Magnetic Resonance Gd-RGD Imaging Study of Hepatocellular Carcinoma with High and Low Metastatic Potential before and after Human Bone Marrow-derived Mesenchymal Stem Cell Intervention.
Li TR; Yu MH; Huang XB; Yang ZJ; Lu GM; Li YJ
Chin Med J (Engl); 2017 Nov; 130(21):2591-2600. PubMed ID: 29067958
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of MRI with extracellular vs. hepatobiliary contrast material for detection of residual hepatocellular carcinoma after locoregional treatment.
Rimola J; Davenport MS; Liu PS; Brown T; Marrero JA; McKenna BJ; Hussain HK
Abdom Radiol (NY); 2019 Feb; 44(2):549-558. PubMed ID: 30218239
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M
Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939
[TBL] [Abstract][Full Text] [Related]
27. Hybrid Calcium Phosphate-Polymeric Micelles Incorporating Gadolinium Chelates for Imaging-Guided Gadolinium Neutron Capture Tumor Therapy.
Mi P; Dewi N; Yanagie H; Kokuryo D; Suzuki M; Sakurai Y; Li Y; Aoki I; Ono K; Takahashi H; Cabral H; Nishiyama N; Kataoka K
ACS Nano; 2015 Jun; 9(6):5913-21. PubMed ID: 26033034
[TBL] [Abstract][Full Text] [Related]
28. A multifunctional targeted nanoprobe with high NIR-II PAI/MRI performance for precise theranostics of orthotopic early-stage hepatocellular carcinoma.
He L; Zhang Y; Chen J; Liu G; Zhu J; Li X; Li D; Yang Y; Lee CS; Shi J; Yin C; Lai P; Wang L; Fang C
J Mater Chem B; 2021 Nov; 9(42):8779-8792. PubMed ID: 34635903
[TBL] [Abstract][Full Text] [Related]
29. Sorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment.
Xiao Y; Liu Y; Yang S; Zhang B; Wang T; Jiang D; Zhang J; Yu D; Zhang N
Colloids Surf B Biointerfaces; 2016 May; 141():83-92. PubMed ID: 26844644
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis.
Guo J; Seo Y; Ren S; Hong S; Lee D; Kim S; Jiang Y
Abdom Radiol (NY); 2016 Oct; 41(10):1960-72. PubMed ID: 27318936
[TBL] [Abstract][Full Text] [Related]
31. Tumor-Microenvironment Relaxivity-Changeable Gd-Loaded Poly(L-lysine)/Carboxymethyl Chitosan Nanoparticles as Cancer-Recognizable Magnetic Resonance Imaging Contrast Agents.
Jiang D; Zhang X; Yu D; Xiao Y; Wang T; Su Z; Liu Y; Zhang N
J Biomed Nanotechnol; 2017 Mar; 13(3):243-54. PubMed ID: 29381026
[TBL] [Abstract][Full Text] [Related]
32. Gadolinium-Loaded Solid Lipid Nanoparticles as a Tumor-Absorbable Contrast Agent for Early Diagnosis of Colorectal Tumors Using Magnetic Resonance Colonography.
Sun J; Zhang S; Jiang S; Bai W; Liu F; Yuan H; Ji J; Luo J; Han G; Chen L; Jin Y; Hu P; Yu L; Yang X
J Biomed Nanotechnol; 2016 Sep; 12(9):1709-23. PubMed ID: 29345451
[TBL] [Abstract][Full Text] [Related]
33. Albumin-based nanoparticles loaded with hydrophobic gadolinium chelates as T
Wang L; Lin H; Ma L; Jin J; Shen T; Wei R; Wang X; Ai H; Chen Z; Gao J
Nanoscale; 2017 Mar; 9(13):4516-4523. PubMed ID: 28317976
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
[TBL] [Abstract][Full Text] [Related]
35. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC
PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258
[TBL] [Abstract][Full Text] [Related]
36. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.
Korkusuz H; Knau LL; Kromen W; Bihrer V; Keese D; Piiper A; Vogl TJ
J Magn Reson Imaging; 2012 Jun; 35(6):1397-402. PubMed ID: 22267126
[TBL] [Abstract][Full Text] [Related]
37. Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging.
Min JH; Kim YK; Choi SY; Kang TW; Jeong WK; Kim K; Won HJ
Br J Radiol; 2018 Oct; 91(1090):20180177. PubMed ID: 29927634
[TBL] [Abstract][Full Text] [Related]
38. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
39. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.
Wu JW; Yu YC; Qu XL; Zhang Y; Gao H
World J Gastroenterol; 2018 Jan; 24(3):415-423. PubMed ID: 29391764
[TBL] [Abstract][Full Text] [Related]
40. The natural history of streptozotocin-stimulated non-alcoholic steatohepatitis mice followed by Gd-EOB-DTPA-enhanced MRI: Comparison with simple steatosis mice.
Akai H; Kiryu S; Ohta Y; Yasaka K; Nakano Y; Inoue Y; Ohtomo K
Magn Reson Imaging; 2017 May; 38():123-128. PubMed ID: 28062263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
